Relation Between Oculocardiac Reflex and Laryngospasm
Evaluation of Correlation Between Laryngospasm, Emergence Agitation and Oculocardiac Reflex in Strabismus Surgery
1 other identifier
observational
120
1 country
1
Brief Summary
The aim of this study is to evaluate whether there is a significant relation between various arrhythmias during the surgeon's stretching the eye muscles and laryngospasm and emergence agitation in strabismus surgeries
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2021
CompletedFirst Submitted
Initial submission to the registry
February 10, 2022
CompletedFirst Posted
Study publicly available on registry
April 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2022
CompletedApril 21, 2022
February 1, 2022
1.4 years
February 10, 2022
April 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Laryngospasm ratio
Laryngospasm during emergence in patients with oculocardiac reflex in surgery will be recorded
an average of 20 minutes during emergence
Secondary Outcomes (2)
Emergence agitation in children
an average of 30 minutes
Emergence agitation in adults
an average of 30 minutes
Eligibility Criteria
Pediatric and adult patients whose ages ranged between 2-18 and 18-65 and from the group of American Society of Anesthesiology (ASA) I-II who will have elective strabismus surgery
You may qualify if:
- Scheduled for the strabismus surgery
- ASA 1-2 patients
- yo patients
You may not qualify if:
- Patients with kidney, cardiac diseases
- Being treated with sedative or anticonvulsant drugs
- ASA 3-4 patients
- Patients with upper respiratory tract disease in the last 2 weeks
- Patients who do not want to participate in the study
- Patients with behavioral disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erciyes University
Kayseri, Melikgazi, 38039, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Adnan Bayram, Professor
TC Erciyes University
- PRINCIPAL INVESTIGATOR
Ahmet Cakir, MD
TC Erciyes University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 10, 2022
First Posted
April 21, 2022
Study Start
January 4, 2021
Primary Completion
May 15, 2022
Study Completion
May 15, 2022
Last Updated
April 21, 2022
Record last verified: 2022-02